Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-02

Clinical Trial Update: A Pilot Study of Terazosin for Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Pilot study of terazosin for Parkinson's disease has completed Phase 1 and Phase 2 trials with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terazosin (terazosin)

Snippet

Sponsor: Jordan Schultz | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-08-02